Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats (2021)
- Authors:
- USP affiliated authors: LARA, VANESSA SOARES - FOB ; SANTOS, CARLOS FERREIRA DOS - FOB
- Unidade: FOB
- DOI: 10.1016/j.ejphar.2021.174609
- Subjects: CÉLULAS ESTROMAIS; HIPERTENSÃO; MEDULA ÓSSEA DE ANIMAL; RATOS; OSTEOGÊNESE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 912, id. 174609, 10 p., Dec. 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
- Licença: publisher-specific-oa
-
ABNT
BRITO, Victor Gustavo Balera et al. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats. European Journal of Pharmacology, v. 912, p. 10 , 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2021.174609. Acesso em: 02 nov. 2024. -
APA
Brito, V. G. B., Patrocinio, M. S., Barreto, A. E. A., Frasnelli, S. C. T., Lara, V. S., Santos, C. F. dos, & Oliveira, S. H. P. de. (2021). Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats. European Journal of Pharmacology, 912, 10 . doi:10.1016/j.ejphar.2021.174609 -
NLM
Brito VGB, Patrocinio MS, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP de. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats [Internet]. European Journal of Pharmacology. 2021 ; 912 10 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2021.174609 -
Vancouver
Brito VGB, Patrocinio MS, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP de. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats [Internet]. European Journal of Pharmacology. 2021 ; 912 10 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2021.174609 - Mast cells contribute to alveolar bone loss in Spontaneously Hypertensive Rats with periodontal disease regulating cytokines production
- Role of mast cell and RAS in mice periodontal tissue
- Mast cells supernatant inhibit bone formation markers gene expression in SHR osteoblasts
- Corrigendum: Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease
- Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease
- Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease
- Mast cells increase gene expression of osteoclastogenic markers in SHR
- Morphologic evaluation and expression of matrix metalloproteinases-2 and 9 and nitric oxide during experimental periodontal disease in rat
- Losartan plays a fungistatic and fungicidal activity against candida albicans biofilms: drug repurposing for localized candidosis
- Evaluation of SAP expression in experimental model of denture stomatitis
Informações sobre o DOI: 10.1016/j.ejphar.2021.174609 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
